Testing targeted treatments for thymus cancer using tumor testing
Part of Blood & lymphatic, Cancer clinical trials.
This trial studies people with thymus (thymic) cancers that have been confirmed by tissue testing. It uses tumor “molecular” (biologic/genetic) test results to guide treatment options and see how well they work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of thymus cancer based on a tissue biopsy or surgery report
- You are 18 years old or older
- You can understand the trial and are willing to sign a consent form
- You will need to provide or allow testing of your tumor as part of the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether additional chemotherapy after surgery can help prevent thymic cancer from coming back. It is for people who have had their thymus tumor completely removed and are in good health.
This trial tests a new treatment given before surgery for people with advanced thymic carcinoma. It aims to shrink the tumor and make surgery more effective.
This trial tests combining surgery with heated chemotherapy delivered directly into the chest cavity for people whose thymus cancer has spread to the lining of the lung. The goal is to see if this approach is safe and effective.
This trial tests giving chemotherapy directly into the chest cavity during surgery for thymoma that has spread to the lining of the lung (pleura) or has come back there. The goal is to see if this approach can help control the disease and improve outcomes.
This trial tests a new drug, sacituzumab tirumotecan, in people with advanced thymic carcinoma that has spread or cannot be removed with surgery. It is for those whose cancer has gotten worse after at least one round of platinum-based chemotherapy.
This study looks at the genetic changes (molecular analysis) in certain cancers of the chest. It may help doctors learn more about what drives these cancers and how they might be diagnosed or treated in the future.
Hear when a new Thymic Epithelial Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.